Skip to main content

How to Profit in a $29 Billion “New Biotech” Sector

Back in the late 1960s and early 1970s, psychedelics drugs like LSD were still legal and could be researched. But in 1968 when the federal government criminalized them, a lot of promising research stopped. Now the spotlight is back on these drugs and the success they’ve shown in clinical trials for treating a range of mental health conditions. This is not only great news for people suffering from these conditions, but also for savvy investors who’ll get in on the ground floor of a market that could be worth more than $29 billion by the end of the decade. Here’s Shah with all the details…. Read more... Tags: Stocks to Buy The post How to Profit in a $29 Billion “New Biotech” Sector appeared first on Money Morning - We Make Investing Profitable .
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.